Marker combination, method, and system for immune checkpoint PD-1/PD-L1 dynamic monitoring
A PD-L1 and immune checkpoint technology, applied in the field of marker combinations for dynamic monitoring of immune checkpoint PD-1/PD-L1, can solve the problem of inability to distinguish which cell the positive signal appears in, and cannot accurately reflect the patient's effect, etc. question
Inactive Publication Date: 2020-12-01
WUHAN UNIV
View PDF2 Cites 4 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
In the interpretation of traditional immunohistochemical results, HE stained sections should be observed first to determine the number and location of tumor cells in the section, and then observe PD-L1 immunohistochemical sections under a low-power microscope to determine whether PD-L1 is positive and whether it is positive. Finally, under a hig
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Example Embodiment
[0054] Example:
[0055] Research objects:
[0056] The mouse subcutaneous xenograft model made by the PD-L1-overexpressing NCI-H1299 lung cancer cell line was selected as the research object, and this cell line has no mutations of EGFR, ALK and K-ras. They were divided into model group and PD-L1 antibody treatment group.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more
Abstract
The invention discloses a marker combination, a method and a system for dynamically monitoring an immune checkpoint PD-1/PD-L1. According to the method, an Opal/TSA multi-label immunofluorescence technology is adopted to simultaneously detect a plurality of markers related to tumor immunity in tumor tissues, and a Vectra automatic multispectral quantitative pathological image analysis system is combined to carry out data processing. The method disclosed by the invention can be used for guiding the actual medication of the tumor immunosuppressor; on the same tissue, different immune detection points and immune cell markers can detect signals, subtyping can be conducted on cells, cells of all phenotypes are obtained, and a theoretical basis is provided for treatment effect judgment of tumorpatients before and after treatment and guidance of tumor immunotherapy. Dynamic detection can be provided for the curative effect of tumor immunotherapy, clinical medication can be better guided, andmore tumor patients can be benefited from immunotherapy; compared with the conventional immunohistochemical detection technology, the detection target is richer and more intuitive.
Description
technical field [0001] The invention relates to the technical field of biomedicine, in particular to a marker combination, method and system for dynamic monitoring of immune checkpoint PD-1 / PD-L1. Background technique [0002] In today's society, due to the influence of various factors such as population aging, lifestyle and living environment, cancer has become the focus of the whole society. According to WHO data, 1 / 6 of the population's death worldwide is due to cancer, and 1 / 2 of the population will develop different types of tumors throughout their life cycle. In recent years, as a new revolutionary technology for tumor treatment, immunotherapy, especially immune checkpoint therapy, has developed rapidly. Multiple programmed death receptor / ligand-1 (PD-1 / PD-L1) inhibitors have been used in lung cancer, Clinical approval has been rapidly obtained in more than a dozen malignant tumors such as liver cancer and melanoma. How to improve the efficacy of PD-1 / PD-L1 inhibitor...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more
IPC IPC(8): G01N33/574G01N33/68
CPCG01N33/57407G01N33/57415G01N33/57423G01N33/57438G01N33/57446G01N33/57484G01N33/6872G01N2800/60
Inventor 陈洪雷杨雨寒赵晨袁毓田素芳
Owner WUHAN UNIV
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap